ImStar Therapeutics
-
2012
Company Description
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis.
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis. Its product pipeline is comprised of IMS-088, a small-molecule compound designed to address immune system activation pathway involved in neurodegeneration; and TDP-43 Associated NF-kB Activation Inhibitors.ImStar Therapeutics was founded in 2012 and is based in Vancouver, Canada.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Company Website:
-
Company E-mail:
-
Company Address:
1285 West Broadway, Suite 600Vancouver, BCCanada -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits